-
Rheumatology
In the UK, the impact of musculoskeletal conditions on work is demanding more attention from all stakeholders, including clinicians and policymakers. National policies directed at extending working life, Dame Carol Black's report ‘Working for a Healthier Tomorrow’ and the subsequent government response ‘Improving health and work: changing lives’ highlight the topic and the need for new approaches and attitudes.
Rheumatology - Fri, 26 June 2009
http://rheumatology.oxfordjournals.org/
-
Cardiology
To understand and promote vascular health, we must reduce the aggression to the vessel wall and enhance the physiologic mechanisms leading to restoration of vessel wall function. Three main defense mechanisms are responsible for maintaining cardiovascular homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis, and macrophage-mediated reverse cholesterol transport. Endothelial progenitor cells can restore vessel wall function and reduce atherosclerosis.
Journal of the American College of Cardiology - Fri, 26 June 2009
http://content.onlinejacc.org/
-
Oncology
In the WACS (Women's Antioxidant Cardiovascular Study) trial, performed in 2007, 7187 women with cardiac risk factors were treated with vitamin C, vitamin E, beta carotene and placebo.
MedNews - Fri, 26 June 2009
http://mn.medsurfnews.com/
-
Oncology
The reduction of prostate cancer risk through the administration of vitamin C or E or selenium has been discussed, but up to now trials have not confirmed this effect by antioxidants. Now, two new investigations are available: in the first one, 35,533 males older than 50, without prostate cancer, have been treated with 200 μg of selenium a day, 400 UI of vitamin E, both products or none of them. They have been invited to undergo yearly prostate controls: about 85% of them measured yearly PSA and 70% underwent rectal exploration.
MedNews - Fri, 26 June 2009
http://mn.medsurfnews.com/
-
Orthopaedics
Patients undergoing elbow X-rays for injuries are, in most cases, without fractures, so researchers thought it was necessary to verify whether there is the possibility to exclude a fracture without using X-ray exams. Some English researchers have examined more than 1700 adults and children with elbow injuries, verifying the joint extension, judged as normal in the presence of the greatest and symmetric extension with supine arms and bent shoulders at 90°.
MedNews - Fri, 26 June 2009
http://mn.medsurfnews.com/
-
Cardiology
A peripheral arterial disease can be hypothesized when the ankle-brachial index (ABI) is lower than 0.70. Some researchers in California have measured ABI and recorded cardiovascular risk factors in 508 subjects, followed for 6 years. Through analyses adjusted for the various cardiovascular risk factors, it was seen that the lowest ABI indexes were significantly associated with an increased overall mortality, cardiovascular mortality and mortality associated with cardiovascular morbidity.
MedNews - Fri, 26 June 2009
http://mn.medsurfnews.com/
-
Cardiology
Comprehensive overview covers symptoms, causes and treatment of this type of chest pain.
MayoClinic.com - Fri, 26 June 2009
http://www.mayoclinic.com
-
Infectious Diseases
As of June 15, nearly 36 000 people in 76 countries have been infected with influenza A (H1N1) and 163 have died. Last week, WHO raised the pandemic alert level from phase 5 to 6—the highest level—officially signifying the start of the first influenza pandemic since 1968. Phase 6 means that there are now sustained community level outbreaks of infection in countries in two continents.
The Lancet - Fri, 26 June 2009
http://www.thelancet.com
-
General medicine
On June 15, a new alliance of research funding agencies—including the US National Institutes of Health, the UK's Medical Research Council, the Canadian Institutes of Health Research, Australia's National Health Medical Research Council, and China's Ministry of Health—was launched to lead and coordinate research into chronic diseases worldwide.
The Lancet - Fri, 26 June 2009
http://www.thelancet.com
-
Oncology
The National Institute for Health and Clinical Excellence (NICE) has today (24 June) published guidance on cetuximab for the treatment of recurrent and/or metastatic (where the cancer has spread) squamous cell cancer of the head and neck.
National Institute for Health and Clinical Excellence - Fri, 26 June 2009
http://www.nice.org.uk